IDIA Relative Valuation - Idorsia Ltd - Alpha Spread

Idorsia Ltd
SIX:IDIA

Watchlist Manager
Idorsia Ltd Logo
Idorsia Ltd
SIX:IDIA
Watchlist
Price: 1.525 CHF 0.07% Market Closed
Market Cap: 323.3m CHF
Have any thoughts about
Idorsia Ltd?
Write Note

Relative Value

The Relative Value of one IDIA stock under the Base Case scenario is 13.968 CHF. Compared to the current market price of 1.525 CHF, Idorsia Ltd is Undervalued by 89%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IDIA Relative Value
Base Case
13.968 CHF
Undervaluation 89%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
73
Median 3Y
27.7
Median 5Y
72.2
Industry
7.7
Forward
3.3
vs History
4
vs Industry
Median 3Y
-3.4
Median 5Y
-6.9
Industry
23.9
Forward
-1.1
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-6.4
Industry
22.2
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-4.6
Industry
24
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-0.4
Industry
2.5
vs History
85
vs Industry
46
Median 3Y
34.5
Median 5Y
72
Industry
7.4
Forward
10.2
vs History
33
vs Industry
44
Median 3Y
8.6
Median 5Y
0
Industry
8.5
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-5.6
Industry
5.1
Forward
-2.8
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-6.3
Industry
4.7
Forward
-2.7
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-6.5
Industry
6.6
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-6.2
Industry
4.7
vs History
92
vs Industry
43
Median 3Y
8.3
Median 5Y
9.6
Industry
4.7

Multiples Across Competitors

IDIA Competitors Multiples
Idorsia Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Idorsia Ltd
SIX:IDIA
323.3m CHF 2.5 11.3 -3 -2.8
US
Abbvie Inc
NYSE:ABBV
341.9B USD 6.2 64.6 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
180.5B USD 5.8 57.7 20.2 36.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
127.8B USD 9.5 29.6 25.9 28.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.3B USD 11.9 -251.7 26.8 28.1
US
Gilead Sciences Inc
NASDAQ:GILD
104.5B USD 3.8 99.3 9.4 12
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
AU
CSL Ltd
ASX:CSL
142.3B AUD 6.5 36.7 22.4 27.9
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.4B USD 15.1 -485.3 213.7 328.9
P/E Multiple
Earnings Growth
CH
Idorsia Ltd
SIX:IDIA
Average P/E: 49.8
11.3
N/A
US
Abbvie Inc
NYSE:ABBV
64.6
406%
US
Amgen Inc
NASDAQ:AMGN
57.7
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.6
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -251.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
99.3
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
36.7
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -485.3 N/A
EV/EBITDA Multiple
EBITDA Growth
CH
Idorsia Ltd
SIX:IDIA
Average EV/EBITDA: 47.7
Negative Multiple: -3
N/A
US
Abbvie Inc
NYSE:ABBV
15.8
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.9
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
39%
US
Gilead Sciences Inc
NASDAQ:GILD
9.4
10%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550.7 N/A
AU
CSL Ltd
ASX:CSL
22.4
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -63 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
213.7
N/A
EV/EBIT Multiple
EBIT Growth
CH
Idorsia Ltd
SIX:IDIA
Average EV/EBIT: 69.5
Negative Multiple: -2.8
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
36.6
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.7
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.1
38%
US
Gilead Sciences Inc
NASDAQ:GILD
12
26%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -536 N/A
AU
CSL Ltd
ASX:CSL
27.9
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.9 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 173.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
328.9
N/A

See Also

Discover More
Back to Top